10XHealth: Module 4 on ”Strategic finance and health economics for impact experts”

Last Thursday, together with SmiLe Venture Hub, we organised Module 4 of our accelerator programme 10XHealth. C-level leaders from our seven participating companies joined us to explore ”Strategic finance and health economics for impact experts”, expertly guided by SmiLe Venture Hub’s Thomas Unt and Åke Bengtsson, and SmartStep Nordics’ Peter Hertzman and Fredrik Ståhl.

Here’s some learnings from expert Åke Bengtsson after module 4:

Would you please list three major challenges to scale-ups regarding the expert area you represented with your module, and examples of how to deal with them?

1. Company valuation – basic valuation methods like Discounted Cash Flow are necessary calculations to support the investment story and to verify the valuation of the company. Documentation to support valuation are required in dialogues with investors and lenders in the scale up phase.
2.  Leverage finance – utilize debt financing will lower the cost of capital for the company and attract the equity investor to achieve higher return on investments.
3. Business model design – with aim to support cash needs during scale up phase should be outlined in the early stage of defining the commercial business growth strategy.

Over 10 months, these scale-ups is taking part in a tailor-made journey designed to accelerate life science innovation. The programme is powered by Medicon Village Innovation and SmiLe Venture Hub, and co-financed by the European Regional Development Fund.

More on 10XHealth at https://10xhealth.se.